Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
Anita A. Pinar(Monash University), Chrishan S. Samuel(Discovery Institute)
Cited by 33
Related Papers
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
|Nature Communications|2018|190
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
|PLoS ONE|2012|129
Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis
|American Journal Of Pathology|2011|94
Antifibrotic Properties of Relaxin: In Vivo Mechanism of Action in Experimental Renal Tubulointerstitial Fibrosis
|Endocrinology|2010|72
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
|Scientific Reports|2017|62